Description
Recombinant monoclonal antibody to HLA-DR10. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma Lym-1. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques.
Target
HLA-DR10
Target Alias Names
CD74, Beta chain HLA-DR, HLA-DR β-chain, β-chain, HLA class II histocompatibility antigen gamma chain, HLA-DR antigens-associated invariant chain, Ia antigen-associated invariant chain, Ii, p33
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression